FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

AAGILENT TECHNOLOGIES, INC.

Inspect →

AAAlcoa Corp

Inspect →

AAAUGoldman Sachs Physical Gold ETF

Inspect →

AACAres Acquisition Corp III

Inspect →

AACGATA Creativity Global

Inspect →

AACIArmada Acquisition Corp. III

Inspect →

AACOAbony Acquisition Corp. I

Inspect →

AACPApogee Acquisition Corp

Inspect →

AADXApplied Aerospace & Defense, Inc.

Inspect →

AAGHAmerica Great Health

Inspect →

AALAmerican Airlines Group Inc.

Inspect →

AAMEATLANTIC AMERICAN CORP

Inspect →

03 / FINANCIAL CHANGES

Janux Therapeutics, Inc. JANX

Pharmaceutical Preparations · SIC 2834

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-05 · Retrieved: 2026-11-10

Compared with the same period of the prior year, ending 2025-09-30.

Revenue9.29

USD million

Change year over year: -0.71 · -7.1%

Net income-21.57

USD million

Change year over year: +2.74

Operating cash flow-25.18

USD million

Change year over year: -12.33

Total liabilities72.04

USD million

Change year over year: +23.83

Total assets983.66

USD million

Change year over year: -41.11

Liabilities / assets: 7.3% · Change: +2.6 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-02-26 · Retrieved: 2026-11-10

Compared with the same period of the prior year, ending 2024-12-31.

Revenue10.00

USD million

Change year over year: -0.59 · -5.6%

Net income-113.63

USD million

Change year over year: -44.63

Operating cash flow-82.24

USD million

Change year over year: -38.42

Total liabilities44.74

USD million

Change year over year: +6.01

Total assets1,001.57

USD million

Change year over year: -59.95

Liabilities / assets: 4.5% · Change: +0.8 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
OCUL ↗	2025-12-31	51.95	-511.9%	-394.4%
HROW ↗	2025-12-31	272.30	-1.9%	16.1%
IRD ↗	2025-12-31	14.20	-349.3%	-248.3%
INO ↗	2025-12-31	0.07	-130,000.0%	-135,637.2%
SIGA ↗	2025-12-31	94.57	24.6%	46.0%
TGTX ↗	2025-12-31	616.29	72.6%	-4.0%

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

GEVO ↗

Gevo, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

AVNW ↗

AVIAT NETWORKS, INC.

Filed: 2026-11-10
Period ending: 2026-10-02

Latest standalone quarter

NCMI ↗

National CineMedia, Inc.

Filed: 2026-11-10
Period ending: 2026-10-01

Latest annual report

SBH ↗

Sally Beauty Holdings, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

SNOA ↗

Sonoma Pharmaceuticals, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

PALI ↗

PALISADE BIO, INC.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

IPM ↗

INTELLIGENT PROTECTION MANAGEMENT CORP.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

KUST ↗

KUSTOM ENTERTAINMENT, INC.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

NLST ↗

NETLIST INC

Filed: 2026-11-10
Period ending: 2026-09-26

Latest standalone quarter

DLPN ↗

Dolphin Entertainment, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Latest standalone quarter

BGS ↗

B&G Foods, Inc.

Filed: 2026-11-10
Period ending: 2026-10-03

Latest standalone quarter

LNSR ↗

LENSAR, Inc.

Filed: 2026-11-10
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →